❌

Normal view

BLM$_1$: A Boundless Large Model for Cross-Space, Cross-Task, and Cross-Embodiment Learning

arXiv:2510.24161v1 Announce Type: new Abstract: Multimodal large language models (MLLMs) have advanced vision-language reasoning and are increasingly deployed in embodied agents. However, significant limitations remain: MLLMs generalize poorly across digital-physical spaces and embodiments; vision-language-action models (VLAs) produce low-level actions yet lack robust high-level embodied reasoning; and most embodied large language models (ELLMs) are constrained to digital-space with poor generalization to the physical world. Thus, unified models that operate seamlessly across digital and physical spaces while generalizing across embodiments and tasks remain absent. We introduce the \textbf{Boundless Large Model (BLM$_1$)}, a multimodal spatial foundation model that preserves instruction following and reasoning, incorporates embodied knowledge, and supports robust cross-embodiment control. BLM$_1$ integrates three key capabilities -- \textit{cross-space transfer, cross-task learning, and cross-embodiment generalization} -- via a two-stage training paradigm. Stage I injects embodied knowledge into the MLLM through curated digital corpora while maintaining language competence. Stage II trains a policy module through an intent-bridging interface that extracts high-level semantics from the MLLM to guide control, without fine-tuning the MLLM backbone. This process is supported by a self-collected cross-embodiment demonstration suite spanning four robot embodiments and six progressively challenging tasks. Evaluations across digital and physical benchmarks show that a single BLM$_1$ instance outperforms four model families -- MLLMs, ELLMs, VLAs, and GMLMs -- achieving $\sim\!\textbf{6%}$ gains in digital tasks and $\sim\!\textbf{3%}$ in physical tasks.

Integrating Genomics into Multimodal EHR Foundation Models

arXiv:2510.23639v1 Announce Type: cross Abstract: This paper introduces an innovative Electronic Health Record (EHR) foundation model that integrates Polygenic Risk Scores (PRS) as a foundational data modality, moving beyond traditional EHR-only approaches to build more holistic health profiles. Leveraging the extensive and diverse data from the All of Us (AoU) Research Program, this multimodal framework aims to learn complex relationships between clinical data and genetic predispositions. The methodology extends advancements in generative AI to the EHR foundation model space, enhancing predictive capabilities and interpretability. Evaluation on AoU data demonstrates the model's predictive value for the onset of various conditions, particularly Type 2 Diabetes (T2D), and illustrates the interplay between PRS and EHR data. The work also explores transfer learning for custom classification tasks, showcasing the architecture's versatility and efficiency. This approach is pivotal for unlocking new insights into disease prediction, proactive health management, risk stratification, and personalized treatment strategies, laying the groundwork for more personalized, equitable, and actionable real-world evidence generation in healthcare.

Closing Gaps: An Imputation Analysis of ICU Vital Signs

arXiv:2510.24217v1 Announce Type: cross Abstract: As more Intensive Care Unit (ICU) data becomes available, the interest in developing clinical prediction models to improve healthcare protocols increases. However, the lack of data quality still hinders clinical prediction using Machine Learning (ML). Many vital sign measurements, such as heart rate, contain sizeable missing segments, leaving gaps in the data that could negatively impact prediction performance. Previous works have introduced numerous time-series imputation techniques. Nevertheless, more comprehensive work is needed to compare a representative set of methods for imputing ICU vital signs and determine the best practice. In reality, ad-hoc imputation techniques that could decrease prediction accuracy, like zero imputation, are still used. In this work, we compare established imputation techniques to guide researchers in improving the performance of clinical prediction models by selecting the most accurate imputation technique. We introduce an extensible and reusable benchmark with currently 15 imputation and 4 amputation methods, created for benchmarking on major ICU datasets. We hope to provide a comparative basis and facilitate further ML development to bring more models into clinical practice.

The Role of Omentin in Gastrointestinal Cancer: Diagnostic, Prognostic, and Therapeutic Perspectives

Metabolites. 2025 Sep 30;15(10):649. doi: 10.3390/metabo15100649.

ABSTRACT

Background/Objectives: Omentin, also known as intelectin-1, is a secreted adipokine with anti-inflammatory, insulin-sensitizing, and immune-modulatory functions, primarily expressed in visceral adipose tissue. While omentin has been associated with favorable metabolic outcomes, its role in cancer pathogenesis appears context-dependent and remains poorly understood. This review investigates the biological functions, expression patterns, and clinical relevance of omentin across gastrointestinal malignancies. Methods: A comprehensive review of the literature was conducted using PubMed, Scopus, and Web of Science up to August 2025 to evaluate the role of omentin in gastrointestinal cancers. Both preclinical and clinical studies evaluating omentin, its analogues and omentin-enhancing agents in gastric, colorectal, hepatic, pancreatic, and esophageal cancers were included. Results: Omentin exhibits anti-proliferative, anti-inflammatory, and anti-angiogenic effects within the tumor microenvironment in several GI malignancies. However, evidence also indicates a dual role. High intratumoral omentin expression correlates with improved prognosis in colorectal, gastric, and hepatic cancers; in contrast, elevated circulating levels-particularly in colorectal and pancreatic cancers-have been paradoxically associated with increased cancer risk and poor outcomes. Mechanistically, omentin modulates PI3K/Akt, NF-κB, AMPK, and oxidative stress pathways, and interacts with TMEM207. However, most available studies are small-scale and heterogeneous, with methodological inconsistencies and limited multi-omics integration, leaving major knowledge gaps. Conclusions: This review highlights omentin's distinct systemic and local roles across GI cancers, underscoring its translational implications. Omentin emerges as a promising but context-dependent biomarker and therapeutic target, with future research needed to address heterogeneity, standardize assays, and validate its clinical utility in large-scale prospective studies.

PMID:41149627 | PMC:PMC12566161 | DOI:10.3390/metabo15100649

Navigating Cancer Complexity: Integrative Multi-Omics Methodologies for Clinical Insights

Clin Med Insights Oncol. 2025 Oct 21;19:11795549251384582. doi: 10.1177/11795549251384582. eCollection 2025.

ABSTRACT

Recent advancements in cancer multi-omics have transformed our understanding of cancer biology by integrating genomics, transcriptomics, proteomics, and metabolomics. These integrative approaches have led to the identification of novel biomarkers and therapeutic targets, offering deeper insights into the molecular intricacies of various cancers, including breast, lung, gastric, pancreatic, and glioblastoma. Despite these advances, challenges remain, such as the integration of disparate data types and the interpretation of complex biological interactions. However, developments in proteogenomics and mass spectrometry have enhanced the correlation between molecular profiles and clinical features, refining the prediction of therapeutic responses. Future research in cancer drug discovery is poised to benefit from multi-omics approaches, improving the precision and efficacy of personalized therapies. By developing integrative network-based models, researchers aim to address challenges related to heterogeneity, reproducibility, and data interpretation. A standardized framework for multi-omics data integration could revolutionize cancer research, optimizing the identification of novel drug targets and enhancing our understanding of cancer biology. This complete approach holds the promise of advancing personalized therapies by fully characterizing the molecular landscape of cancer, ultimately improving patient outcomes through more effective and targeted treatment strategies. This narrative review underscores the potential of multi-omics approaches to transform cancer research and improve patient outcomes through more precise and effective treatments.

PMID:41147019 | PMC:PMC12553891 | DOI:10.1177/11795549251384582

Understanding AI Trustworthiness: A Scoping Review of AIES & FAccT Articles

arXiv:2510.21293v2 Announce Type: replace Abstract: Background: Trustworthy AI serves as a foundational pillar for two major AI ethics conferences: AIES and FAccT. However, current research often adopts techno-centric approaches, focusing primarily on technical attributes such as reliability, robustness, and fairness, while overlooking the sociotechnical dimensions critical to understanding AI trustworthiness in real-world contexts. Objectives: This scoping review aims to examine how the AIES and FAccT communities conceptualize, measure, and validate AI trustworthiness, identifying major gaps and opportunities for advancing a holistic understanding of trustworthy AI systems. Methods: We conduct a scoping review of AIES and FAccT conference proceedings to date, systematically analyzing how trustworthiness is defined, operationalized, and applied across different research domains. Our analysis focuses on conceptualization approaches, measurement methods, verification and validation techniques, application areas, and underlying values. Results: While significant progress has been made in defining technical attributes such as transparency, accountability, and robustness, our findings reveal critical gaps. Current research often predominantly emphasizes technical precision at the expense of social and ethical considerations. The sociotechnical nature of AI systems remains less explored and trustworthiness emerges as a contested concept shaped by those with the power to define it. Conclusions: An interdisciplinary approach combining technical rigor with social, cultural, and institutional considerations is essential for advancing trustworthy AI. We propose actionable measures for the AI ethics community to adopt holistic frameworks that genuinely address the complex interplay between AI systems and society, ultimately promoting responsible technological development that benefits all stakeholders.

Navigating Cancer Complexity: Integrative Multi-Omics Methodologies for Clinical Insights

Clin Med Insights Oncol. 2025 Oct 21;19:11795549251384582. doi: 10.1177/11795549251384582. eCollection 2025.

ABSTRACT

Recent advancements in cancer multi-omics have transformed our understanding of cancer biology by integrating genomics, transcriptomics, proteomics, and metabolomics. These integrative approaches have led to the identification of novel biomarkers and therapeutic targets, offering deeper insights into the molecular intricacies of various cancers, including breast, lung, gastric, pancreatic, and glioblastoma. Despite these advances, challenges remain, such as the integration of disparate data types and the interpretation of complex biological interactions. However, developments in proteogenomics and mass spectrometry have enhanced the correlation between molecular profiles and clinical features, refining the prediction of therapeutic responses. Future research in cancer drug discovery is poised to benefit from multi-omics approaches, improving the precision and efficacy of personalized therapies. By developing integrative network-based models, researchers aim to address challenges related to heterogeneity, reproducibility, and data interpretation. A standardized framework for multi-omics data integration could revolutionize cancer research, optimizing the identification of novel drug targets and enhancing our understanding of cancer biology. This complete approach holds the promise of advancing personalized therapies by fully characterizing the molecular landscape of cancer, ultimately improving patient outcomes through more effective and targeted treatment strategies. This narrative review underscores the potential of multi-omics approaches to transform cancer research and improve patient outcomes through more precise and effective treatments.

PMID:41147019 | PMC:PMC12553891 | DOI:10.1177/11795549251384582

Benchmarking AI Models in Software Engineering: A Review, Search Tool, and Unified Approach for Elevating Benchmark Quality

arXiv:2503.05860v2 Announce Type: replace-cross Abstract: Benchmarks are essential for unified evaluation and reproducibility. The rapid rise of Artificial Intelligence for Software Engineering (AI4SE) has produced numerous benchmarks for tasks such as code generation and bug repair. However, this proliferation has led to major challenges: (1) fragmented knowledge across tasks, (2) difficulty in selecting contextually relevant benchmarks, (3) lack of standardization in benchmark creation, and (4) flaws that limit utility. Addressing these requires a dual approach: systematically mapping existing benchmarks for informed selection and defining unified guidelines for robust, adaptable benchmark development. We conduct a review of 247 studies, identifying 273 AI4SE benchmarks since 2014. We categorize them, analyze limitations, and expose gaps in current practices. Building on these insights, we introduce BenchScout, an extensible semantic search tool for locating suitable benchmarks. BenchScout employs automated clustering with contextual embeddings of benchmark-related studies, followed by dimensionality reduction. In a user study with 22 participants, BenchScout achieved usability, effectiveness, and intuitiveness scores of 4.5, 4.0, and 4.1 out of 5. To improve benchmarking standards, we propose BenchFrame, a unified framework for enhancing benchmark quality. Applying BenchFrame to HumanEval yielded HumanEvalNext, featuring corrected errors, improved language conversion, higher test coverage, and greater difficulty. Evaluating 10 state-of-the-art code models on HumanEval, HumanEvalPlus, and HumanEvalNext revealed average pass-at-1 drops of 31.22% and 19.94%, respectively, underscoring the need for continuous benchmark refinement. We further examine BenchFrame's scalability through an agentic pipeline and confirm its generalizability on the MBPP dataset. All review data, user study materials, and enhanced benchmarks are publicly released.

Navigating Cancer Complexity: Integrative Multi-Omics Methodologies for Clinical Insights

Clin Med Insights Oncol. 2025 Oct 21;19:11795549251384582. doi: 10.1177/11795549251384582. eCollection 2025.

ABSTRACT

Recent advancements in cancer multi-omics have transformed our understanding of cancer biology by integrating genomics, transcriptomics, proteomics, and metabolomics. These integrative approaches have led to the identification of novel biomarkers and therapeutic targets, offering deeper insights into the molecular intricacies of various cancers, including breast, lung, gastric, pancreatic, and glioblastoma. Despite these advances, challenges remain, such as the integration of disparate data types and the interpretation of complex biological interactions. However, developments in proteogenomics and mass spectrometry have enhanced the correlation between molecular profiles and clinical features, refining the prediction of therapeutic responses. Future research in cancer drug discovery is poised to benefit from multi-omics approaches, improving the precision and efficacy of personalized therapies. By developing integrative network-based models, researchers aim to address challenges related to heterogeneity, reproducibility, and data interpretation. A standardized framework for multi-omics data integration could revolutionize cancer research, optimizing the identification of novel drug targets and enhancing our understanding of cancer biology. This complete approach holds the promise of advancing personalized therapies by fully characterizing the molecular landscape of cancer, ultimately improving patient outcomes through more effective and targeted treatment strategies. This narrative review underscores the potential of multi-omics approaches to transform cancer research and improve patient outcomes through more precise and effective treatments.

PMID:41147019 | PMC:PMC12553891 | DOI:10.1177/11795549251384582

ProfileXAI: User-Adaptive Explainable AI

arXiv:2510.22998v1 Announce Type: new Abstract: ProfileXAI is a model- and domain-agnostic framework that couples post-hoc explainers (SHAP, LIME, Anchor) with retrieval - augmented LLMs to produce explanations for different types of users. The system indexes a multimodal knowledge base, selects an explainer per instance via quantitative criteria, and generates grounded narratives with chat-enabled prompting. On Heart Disease and Thyroid Cancer datasets, we evaluate fidelity, robustness, parsimony, token use, and perceived quality. No explainer dominates: LIME achieves the best fidelity--robustness trade-off (Infidelity $\le 0.30$, $L

Reduced AI Acceptance After the Generative AI Boom: Evidence From a Two-Wave Survey Study

arXiv:2510.23578v1 Announce Type: new Abstract: The rapid adoption of generative artificial intelligence (GenAI) technologies has led many organizations to integrate AI into their products and services, often without considering user preferences. Yet, public attitudes toward AI use, especially in impactful decision-making scenarios, are underexplored. Using a large-scale two-wave survey study (n_wave1=1514, n_wave2=1488) representative of the Swiss population, we examine shifts in public attitudes toward AI before and after the launch of ChatGPT. We find that the GenAI boom is significantly associated with reduced public acceptance of AI (see Figure 1) and increased demand for human oversight in various decision-making contexts. The proportion of respondents finding AI "not acceptable at all" increased from 23% to 30%, while support for human-only decision-making rose from 18% to 26%. These shifts have amplified existing social inequalities in terms of widened educational, linguistic, and gender gaps post-boom. Our findings challenge industry assumptions about public readiness for AI deployment and highlight the critical importance of aligning technological development with evolving public preferences.

Hybrid Deep Learning Framework for Enhanced Diabetic Retinopathy Detection: Integrating Traditional Features with AI-driven Insights

arXiv:2510.21810v1 Announce Type: cross Abstract: Diabetic Retinopathy (DR), a vision-threatening complication of Dia-betes Mellitus (DM), is a major global concern, particularly in India, which has one of the highest diabetic populations. Prolonged hyperglycemia damages reti-nal microvasculature, leading to DR symptoms like microaneurysms, hemor-rhages, and fluid leakage, which, if undetected, cause irreversible vision loss. Therefore, early screening is crucial as DR is asymptomatic in its initial stages. Fundus imaging aids precise diagnosis by detecting subtle retinal lesions. This paper introduces a hybrid diagnostic framework combining traditional feature extraction and deep learning (DL) to enhance DR detection. While handcrafted features capture key clinical markers, DL automates hierarchical pattern recog-nition, improving early diagnosis. The model synergizes interpretable clinical data with learned features, surpassing standalone DL approaches that demon-strate superior classification and reduce false negatives. This multimodal AI-driven approach enables scalable, accurate DR screening, crucial for diabetes-burdened regions.

Impact and Implications of Generative AI for Enterprise Architects in Agile Environments: A Systematic Literature Review

arXiv:2510.22003v1 Announce Type: cross Abstract: Generative AI (GenAI) is reshaping enterprise architecture work in agile software organizations, yet evidence on its effects remains scattered. We report a systematic literature review (SLR), following established SLR protocols of Kitchenham and PRISMA, of 1,697 records, yielding 33 studies across enterprise, solution, domain, business, and IT architect roles. GenAI most consistently supports (i) design ideation and trade-off exploration; (ii) rapid creation and refinement of artifacts (e.g., code, models, documentation); and (iii) architectural decision support and knowledge retrieval. Reported risks include opacity and bias, contextually incorrect outputs leading to rework, privacy and compliance concerns, and social loafing. We also identify emerging skills and competencies, including prompt engineering, model evaluation, and professional oversight, and organizational enablers around readiness and adaptive governance. The review contributes with (1) a mapping of GenAI use cases and risks in agile architecting, (2) implications for capability building and governance, and (3) an initial research agenda on human-AI collaboration in architecture. Overall, the findings inform responsible adoption of GenAI that accelerates digital transformation while safeguarding architectural integrity.

Right Place, Right Time: Market Simulation-based RL for Execution Optimisation

arXiv:2510.22206v1 Announce Type: cross Abstract: Execution algorithms are vital to modern trading, they enable market participants to execute large orders while minimising market impact and transaction costs. As these algorithms grow more sophisticated, optimising them becomes increasingly challenging. In this work, we present a reinforcement learning (RL) framework for discovering optimal execution strategies, evaluated within a reactive agent-based market simulator. This simulator creates reactive order flow and allows us to decompose slippage into its constituent components: market impact and execution risk. We assess the RL agent's performance using the efficient frontier based on work by Almgren and Chriss, measuring its ability to balance risk and cost. Results show that the RL-derived strategies consistently outperform baselines and operate near the efficient frontier, demonstrating a strong ability to optimise for risk and impact. These findings highlight the potential of reinforcement learning as a powerful tool in the trader's toolkit.

Breaking Agent Backbones: Evaluating the Security of Backbone LLMs in AI Agents

arXiv:2510.22620v1 Announce Type: cross Abstract: AI agents powered by large language models (LLMs) are being deployed at scale, yet we lack a systematic understanding of how the choice of backbone LLM affects agent security. The non-deterministic sequential nature of AI agents complicates security modeling, while the integration of traditional software with AI components entangles novel LLM vulnerabilities with conventional security risks. Existing frameworks only partially address these challenges as they either capture specific vulnerabilities only or require modeling of complete agents. To address these limitations, we introduce threat snapshots: a framework that isolates specific states in an agent's execution flow where LLM vulnerabilities manifest, enabling the systematic identification and categorization of security risks that propagate from the LLM to the agent level. We apply this framework to construct the $\operatorname{b}^3$ benchmark, a security benchmark based on 194331 unique crowdsourced adversarial attacks. We then evaluate 31 popular LLMs with it, revealing, among other insights, that enhanced reasoning capabilities improve security, while model size does not correlate with security. We release our benchmark, dataset, and evaluation code to facilitate widespread adoption by LLM providers and practitioners, offering guidance for agent developers and incentivizing model developers to prioritize backbone security improvements.

What Is Your AI Agent Buying? Evaluation, Implications and Emerging Questions for Agentic E-Commerce

arXiv:2508.02630v2 Announce Type: replace Abstract: Online marketplaces will be transformed by autonomous AI agents acting on behalf of consumers. Rather than humans browsing and clicking, AI agents can parse webpages or interact through APIs to evaluate products, and transact. This raises a fundamental question: what do AI agents buy-and why? We develop ACES, a sandbox environment that pairs a platform-agnostic agent with a fully programmable mock marketplace to study this. We first explore aggregate choices, revealing that modal choices can differ across models, with AI agents sometimes concentrating on a few products, raising competition questions. We then analyze the drivers of choices through rationality checks and randomized experiments on product positions and listing attributes. Models show sizeable and heterogeneous position effects: all favor the top row, yet different models prefer different columns, undermining the assumption of a universal ``top'' rank. They penalize sponsored tags, reward endorsements, and sensitivities to price, ratings, and reviews are directionally as expected, but vary sharply across models. Finally, we find that a seller-side agent that makes minor tweaks to product descriptions can deliver substantial market-share gains by targeting AI buyer preferences. Our findings reveal how AI agents behave in e-commerce, and surface concrete seller strategy, platform design, and regulatory questions.

ReXGroundingCT: A 3D Chest CT Dataset for Segmentation of Findings from Free-Text Reports

arXiv:2507.22030v2 Announce Type: replace-cross Abstract: We introduce ReXGroundingCT, the first publicly available dataset linking free-text findings to pixel-level 3D segmentations in chest CT scans. The dataset includes 3,142 non-contrast chest CT scans paired with standardized radiology reports from CT-RATE. Construction followed a structured three-stage pipeline. First, GPT-4 was used to extract and standardize findings, descriptors, and metadata from reports originally written in Turkish and machine-translated into English. Second, GPT-4o-mini categorized each finding into a hierarchical ontology of lung and pleural abnormalities. Third, 3D annotations were produced for all CT volumes: the training set was quality-assured by board-certified radiologists, and the validation and test sets were fully annotated by board-certified radiologists. Additionally, a complementary chain-of-thought dataset was created to provide step-by-step hierarchical anatomical reasoning for localizing findings within the CT volume, using GPT-4o and localization coordinates derived from organ segmentation models. ReXGroundingCT contains 16,301 annotated entities across 8,028 text-to-3D-segmentation pairs, covering diverse radiological patterns from 3,142 non-contrast CT scans. About 79% of findings are focal abnormalities and 21% are non-focal. The dataset includes a public validation set of 50 cases and a private test set of 100 cases, both annotated by board-certified radiologists. The dataset establishes a foundation for enabling free-text finding segmentation and grounded radiology report generation in CT imaging. Model performance on the private test set is hosted on a public leaderboard at https://rexrank.ai/ReXGroundingCT. The dataset is available at https://huggingface.co/datasets/rajpurkarlab/ReXGroundingCT.

Article: Building a RAG Application with Spring Boot, Spring AI, MongoDB Atlas Vector Search, and OpenAI

27 October 2025 at 19:00

The RAG paradigm redefines AI: it combines generative models and business data for accurate, contextualised responses. The article shows how to integrate Spring Boot, Spring AI, MongoDB Atlas and OpenAI into a powerful and flexible pipeline capable of transforming the way businesses access and create value from data, with applications ranging from finance and healthcare to customer service.

By Matteo Rossi

Benchmarking large language models for personalized, biomarker-based health intervention recommendations

npj Digital Medicine, Published online: 27 October 2025; doi:10.1038/s41746-025-01996-2

Benchmarking large language models for personalized, biomarker-based health intervention recommendations

Customizing Open Source LLMs for Quantitative Medication Attribute Extraction across Heterogeneous EHR Systems

arXiv:2510.21027v1 Announce Type: new Abstract: Harmonizing medication data across Electronic Health Record (EHR) systems is a persistent barrier to monitoring medications for opioid use disorder (MOUD). In heterogeneous EHR systems, key prescription attributes are scattered across differently formatted fields and freetext notes. We present a practical framework that customizes open source large language models (LLMs), including Llama, Qwen, Gemma, and MedGemma, to extract a unified set of MOUD prescription attributes (prescription date, drug name, duration, total quantity, daily quantity, and refills) from heterogeneous, site specific data and compute a standardized metric of medication coverage, \emph{MOUD days}, per patient. Our pipeline processes records directly in a fixed JSON schema, followed by lightweight normalization and cross-field consistency checks. We evaluate the system on prescription level EHR data from five clinics in a national OUD study (25{,}605 records from 1{,}257 patients), using a previously annotated benchmark of 10{,}369 records (776 patients) as the ground truth. Performance is reported as coverage (share of records with a valid, matchable output) and record-level exact-match accuracy. Larger models perform best overall: Qwen2.5-32B achieves \textbf{93.4\%} coverage with \textbf{93.0\%} exact-match accuracy across clinics, and MedGemma-27B attains \textbf{93.1\%}/\textbf{92.2\%}. A brief error review highlights three common issues and fixes: imputing missing dosage fields using within-drug norms, handling monthly/weekly injectables (e.g., Vivitrol) by setting duration from the documented schedule, and adding unit checks to prevent mass units (e.g., ``250 g'') from being misread as daily counts. By removing brittle, site-specific ETL and supporting local, privacy-preserving deployment, this approach enables consistent cross-site analyses of MOUD exposure, adherence, and retention in real-world settings.
❌